NCT03460873View on ClinicalTrials.gov

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

CompletedOBSERVATIONAL

Enrollment

432

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 7, 2019

Study Completion Date

November 28, 2019

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

PROCEDURE

holmium laser enucleation of the prostate

undergo holmium laser enucleation of the prostate

Trial Locations (1)

135-710

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT03460873 - Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate | Biotech Hunter | Biotech Hunter